KETAMINE-IN OIL-IN-WATER MULTIPLE EMULSION FOR PROLONGED DRUG RELEASE

1999 ◽  
Vol 20 (1-2) ◽  
pp. 235-245
Author(s):  
S. Zheng ◽  
R.L. Beissinger ◽  
L.R. Sehgal ◽  
D.T. Wasan
1993 ◽  
Vol 41 (4) ◽  
pp. 741-746 ◽  
Author(s):  
Takayuki OHWAKI ◽  
Masahiro NAKAMURA ◽  
Hiroshi OZAWA ◽  
Yoshiaki KAWASHIMA ◽  
Tomoaki HINO ◽  
...  

2018 ◽  
Vol 9 ◽  
pp. 1793-1801 ◽  
Author(s):  
Caihong Liang ◽  
Jiang Wen ◽  
Xiaoming Liao

In this work, a visible-light-controlled drug release platform was constructed for localized and prolonged drug release based on two-layer titania nanotubes (TNTs) fabricated using by an in situ voltage up-anodization process. The visible-light photocatalytic activity is improved by loading Ag onto the TNTs by NaBH4 reduction. Then, the TNTs containing Ag nanoparticles were modified with dodecanethiol (NDM) to create a hydrophobic layer. To demonstrate the visible-light-controlled drug release, the Zn2+ release behavior of the samples was investigated. In the initial 12 h, TNTs without NDM displayed a faster release rate with 29.4% Zn2+ release, which was more than three times that of the TNTs with NDM (8.7% Zn2+ release). Upon visible-light illumination, drug release from the sample coated with NDM was shown to increase due to the photocatalytic decomposition of NDM. The amount of released Zn2+ for this sample increased up to 71.9% within 12 h, indicating visible-light-controlled drug release. This drug release system may exhibit promising application as a localized, prolonged drug delivery platform.


2009 ◽  
Vol 89B (1) ◽  
pp. 148-154 ◽  
Author(s):  
Xia Li ◽  
Xiupeng Wang ◽  
Lingxia Zhang ◽  
Hangrong Chen ◽  
Jianlin Shi

2019 ◽  
Vol 555 ◽  
pp. 36-48 ◽  
Author(s):  
Letícia Streck ◽  
Victor H.V. Sarmento ◽  
Ramon P.R.P.B. de Menezes ◽  
Matheus F. Fernandes-Pedrosa ◽  
Alice M.C. Martins ◽  
...  
Keyword(s):  

2018 ◽  
Author(s):  
Shrikrishnan Sankaran ◽  
Judith Becker ◽  
Christoph Wittmann ◽  
Aránzazu del Campo

A living hydrogel has been developed with metabolically and optogenetically engineered E. coli encapsulated within an agarose-based hydrogel matrix to produce and release deoxyviolacein in response to blue light irradiation. Localized, tunable and prolonged drug release have been demonstrated.<br>


2019 ◽  
Vol 16 (6) ◽  
pp. 548-564
Author(s):  
Shabina Mahmood ◽  
Manal Ali Buabeid ◽  
Kaleem Ullah ◽  
Ghulam Murtaza ◽  
Abdul Mannan ◽  
...  

Objective: The aim of the present study was to design an efficient delivery system with an anticipated swelling and drug release properties for a prolonged drug release as well as to target colon for various hydrophilic drugs. Methods: For this purpose, the pH-responsive hydrogel comprising a combination of Eudragit and acrylic acid was formed. The hydrogels were characterized for spectral (FTIR), thermal (TGA/DSC), structural (XRD), and morphological (SEM) investigations. Oral tolerability was assessed in rabbits for biocompatibility and oral use of the prepared hydrogels. Results: The results showed that an increased incorporation of Eudragit and cross-linking agent retorted the swelling, drug loading, and drug release properties at both acid (pH 1.2) and basic pH (pH 6.8 and 7.4) , while acrylic acid presented the inverse results. The oral tolerability and toxicity studies depicted that the developed hydrogels were safe up to 3800 mg/kg body weight and caused no hematological or histopathological changes when compared with the control group. Conclusion: Therefore, the newly developed formulations presented adequate swelling, drug loading, release behavior, and biocompatibility properties and thus can be used as a promising tool for the colonic delivery of various hydrophilic drugs.


Processes ◽  
2019 ◽  
Vol 7 (6) ◽  
pp. 365 ◽  
Author(s):  
Mine Diril ◽  
Yesim Karasulu ◽  
Miltiadis Toskas ◽  
Ioannis Nikolakakis

Self-emulsifying pellets (SEPs) of Atorvastatin Calcium (AtrCa) were developed and processed into tablets (SETs). Self-emulsifying drug delivery system (SEDDS) composed of oleic acid, Tween 20, Span 80 and N-Methyl-2-pyrolidone gave great solubility improvement and was used as oil in water emulsion for the preparation of SEPs. Due to the high 60% w/w SEDDS content required to achieve a therapeutic dose in the final tablet form, sonication was necessary to improve fluidity and stability. Colloidal silicon dioxide (CSD) and microcrystalline cellulose (MCC) were the solids in the pellet formulation employed at a ratio 7:3, which enabled production of pellets with high SEDDS content and acceptable friability as well. Emulsions were characterized physico-chemically, SEPs for physical properties and reconstitution, and tablets of compressed pellets for mechanical strength, disintegration into pellets and drug release. SEPs compressed with 30% MCC at 60 MPa gave tablets of adequate strength that disintegrated rapidly into pellets within 1 min. Emulsion reconstitution took longer than drug release due to adsorption of SEDDS on CSD, implying dissolution at the pellet surface in parallel to that from the dispersed droplets. Compared to the commercial tablet, drug release from the self-emulsifying forms was faster at pH 1.2 where the drug solubility is poor, but slower at pH 6.8 where the solubility is higher. Permeability and cytotoxicity were also studied using Caco-2 cells. The results showed that drug transport from the apical to basolateral compartment of the test well was 1.27 times greater for SEPs than commercial tablets, but 0.86 times lower in the opposite direction. Statistical analysis confirmed the significance of these results. Toxicity was slightly reduced. Therefore, the increased permeability in conjunction with the protection of the drug being dissolved in the SEDDS droplets, may reduce the overall effect of presystemic metabolism and enhance bioavailability.


2020 ◽  
Vol 160 ◽  
pp. 398-408 ◽  
Author(s):  
Manuela-Maria Iftime ◽  
Liliana Mititelu Tartau ◽  
Luminita Marin

2019 ◽  
Vol 221 (1) ◽  
pp. 1900341 ◽  
Author(s):  
Michael M. Lübtow ◽  
Thomas Lorson ◽  
Tamara Finger ◽  
Florian‐Kai Gröber‐Becker ◽  
Robert Luxenhofer

Sign in / Sign up

Export Citation Format

Share Document